story of the week
Overall Survival With Brentuximab Vedotin in Stage III or IV Hodgkin’s Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma
N. Engl. J. Med 2022 Jul 13;[EPub Ahead of Print], SM Ansell, J Radford, JM Connors, M Długosz-Danecka, WS Kim, A Gallamini, R Ramchandren, JW Friedberg, R Advani, M Hutchings, AM Evens, P Smolewski, KJ Savage, NL Bartlett, HS Eom, JS Abramson, C Dong, F Campana, K Fenton, M Puhlmann, DJ StrausFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.